Cargando…

Treatment of SARS-CoV-2 with high dose oral zinc salts: A report on four patients

Coronavirus 2019 (COVID-19) is a pandemic with substantial mortality and no accepted therapy. We report here on four consecutive outpatients with clinical characteristics (CDC case definition) of and/or laboratory-confirmed COVID-19 who were treated with high dose zinc salt oral lozenges. All four p...

Descripción completa

Detalles Bibliográficos
Autor principal:	Finzi, Eric
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2020
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7834648/ https://www.ncbi.nlm.nih.gov/pubmed/32522597 http://dx.doi.org/10.1016/j.ijid.2020.06.006

Ejemplares similares

The zinc proteome of SARS-CoV-2
por: Andreini, Claudia, et al.
Publicado: (2022)

The great escape? SARS-CoV-2 variants evading neutralizing responses
por: Prévost, Jérémie, et al.
Publicado: (2021)

Interaction of Human ACE2 to Membrane-Bound SARS-CoV-1 and SARS-CoV-2 S Glycoproteins
por: Anand, Sai Priya, et al.
Publicado: (2020)

Immunopharmacological perspective on zinc in SARS-CoV-2 infection
por: Asl, Sima Heydarzadeh, et al.
Publicado: (2021)

Serological responses to the first four doses of SARS-CoV-2 vaccine in patients with inflammatory bowel disease
por: Quan, Joshua, et al.
Publicado: (2022)

Standardization of a flow cytometry SARS-CoV-2 serologic test
por: Simard, Carl, et al.
Publicado: (2022)

Comparison of Four SARS-CoV-2 Neutralization Assays
por: Riepler, Lydia, et al.
Publicado: (2020)

Anthracyclines inhibit SARS-CoV-2 infection
por: Wang, Zhen, et al.
Publicado: (2023)

Serological Response to Three, Four and Five Doses of SARS-CoV-2 Vaccine in Kidney Transplant Recipients
por: Osmanodja, Bilgin, et al.
Publicado: (2022)

Protein-ligand binding interactions of imidazolium salts with SARS CoV-2
por: Satheesh, Dhurairaj, et al.
Publicado: (2020)

Inactivation of SARS-CoV-2 on salt-coated surfaces: an in vitro study
por: Gsell, Monika, et al.
Publicado: (2023)

Antiviral activity of salt-coated materials against SARS-CoV-2
por: Coleman, Christopher M., et al.
Publicado: (2023)

Inhibition of SARS-CoV-2 replication by zinc gluconate in combination with hinokitiol
por: Tao, Xuan, et al.
Publicado: (2022)

Serum Free Zinc Is Associated With Vaccination Response to SARS-CoV-2
por: Chillon, Thilo Samson, et al.
Publicado: (2022)

Antiviral Activity of Zinc Oxide Nanoparticles against SARS-CoV-2
por: Wolfgruber, Stella, et al.
Publicado: (2023)

Comparison of Four Systems for SARS-CoV-2 Antibody at Three Time Points after SARS-CoV-2 Vaccination
por: Seo, Jong Do, et al.
Publicado: (2022)

Acute appendicitis in four children with SARS-CoV-2 infection
por: Meyer, Jessica S., et al.
Publicado: (2021)

Oral manifestations in SARS-CoV-2 infection
por: Tuter, Gulay, et al.
Publicado: (2022)

Efficacy and hazards of 425 nm oral cavity light dosing to inactivate SARS-CoV-2
por: Stockslager, Max A., et al.
Publicado: (2022)

Reactivation of SARS-CoV-2 after Asymptomatic Infection while on High-Dose Corticosteroids. Case Report
por: Patrocínio de Jesus, Rita, et al.
Publicado: (2020)

Multiplex detection and dynamics of IgG antibodies to SARS-CoV2 and the highly pathogenic human coronaviruses SARS-CoV and MERS-CoV
por: Ayouba, Ahidjo, et al.
Publicado: (2020)

Low-dose radiotherapy for SARS-CoV-2 pneumonia
por: Chakrabarti, Deep, et al.
Publicado: (2020)

Innate Immunity Evasion Strategies of Highly Pathogenic Coronaviruses: SARS-CoV, MERS-CoV, and SARS-CoV-2
por: Li, Jin-Yan, et al.
Publicado: (2021)

The effectiveness of various gargle formulations and salt water against SARS-CoV-2
por: Tiong, Vunjia, et al.
Publicado: (2021)

Zinc-embedded fabrics inactivate SARS-CoV-2 and influenza A virus
por: Gopal, Vikram, et al.
Publicado: (2021)

Four SARS-CoV-2 vaccine doses or hybrid immunity in patients on immunosuppressive therapies: a Norwegian cohort study
por: Bjørlykke, Kristin H, et al.
Publicado: (2023)

Evaluating the virucidal activity of four disinfectants against SARS-CoV-2
por: Huang, Yi, et al.
Publicado: (2022)

Evaluation of Four Strategies for SARS-CoV-2 Detection: Characteristics and Prospects
por: Chen, Yuqing, et al.
Publicado: (2022)

Dose prediction for repurposing nitazoxanide in SARS‐CoV‐2 treatment or chemoprophylaxis
por: Rajoli, Rajith K. R., et al.
Publicado: (2020)

Comparative highlights on MERS-CoV, SARS-CoV-1, SARS-CoV-2, and NEO-CoV
por: Goyal, Rajat, et al.
Publicado: (2022)

Humoral Responses Elicited after a Fifth Dose of SARS-CoV-2 mRNA Bivalent Vaccine
por: Tauzin, Alexandra, et al.
Publicado: (2023)

Use of oral antiseptics for SARS-CoV-2 infection()
por: Palop Larrea, Vicente, et al.
Publicado: (2020)

Is the oral cavity relevant in SARS-CoV-2 pandemic?
por: Herrera, David, et al.
Publicado: (2020)

Zinc Iodide in combination with Dimethyl Sulfoxide for treatment of SARS-CoV-2 and other viral infections
por: Hoang, Ba X., et al.
Publicado: (2020)

SARS CoV2 mRNA vaccines: Prolonged dosing intervals and anti-SARS-CoV-2 immunity status
por: Ghazvini, Kiarash, et al.
Publicado: (2022)

SARS CoV2 mRNA vaccines: Prolonged dosing intervals and anti-SARS-CoV-2 immunity status
por: Ghazvini, Kiarash, et al.
Publicado: (2022)

Neutralizing SARS-CoV-2
por: Poeschla, Eric
Publicado: (2020)

Human Coronaviruses SARS-CoV, MERS-CoV, and SARS-CoV-2 in Children
por: Aleebrahim-Dehkordi, Elahe, et al.
Publicado: (2021)

Data mining of coronavirus: SARS-CoV-2, SARS-CoV and MERS-CoV
por: Huh, Jung Eun, et al.
Publicado: (2021)

SARS-CoV, MERS-CoV and SARS-CoV-2: A Diagnostic Challenge
por: Ezhilan, Madeshwari, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_kjd5q18td0pdt6el3binupje24